Abstract
Ischaemic heart disease is responsible for a considerable part of chronic pain in society, and is mainly due to angina pectoris. Improvements in pain relief and treatment continue to be developed, and are likely to improve and become cheaper in the future. Prevention is also of great importance for both individuals and society, and is proving cost-effective. However, we have still to learn much about its complex nature.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hagman M, Jönsson D, Wilhelmssen L. Prevalence of angina pectoris and myocardial infarction in a general population of Swedish men. Acta Med Scand 1977; 201: 571.
Väärt J, Haglund B, Isacsson S-O, Rydén L. Prevalensen för angina pectoris i Skaraborgs län. (In Swedish). Läkartidningen 1981; 78: 3400–3402.
Hammar N, Sandberg E, Ahlbom A et al. Epidemiologisk bevakning av hjärtinfarkter visar värre fall men stor regional skillnad. Läkartidningen 1991; 88: 1770–1776.
Williams A. Screening for risk of CHD: is it a wise use of resources In Oliver M, Ashley-Miller M, Wood D (eds), Screening for Risk of Coronary Heart Disease, Chichester: John Wiley, 1987: 97–106.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Isacsson, S.O. Ischaemic heart disease: disability and costs. Qual Life Res 3 (Suppl 1), S93–S96 (1994). https://doi.org/10.1007/BF00433382
Issue Date:
DOI: https://doi.org/10.1007/BF00433382